Biotech · Private company · Los Angeles, CA, US
Allerdia Inc
Track this companyFree. Adds Allerdia Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of a highly sensitive and specific POCT testing asthma triggering allergic IgEFiscal year 2025 · $921.5KNIH RePORTER 5R44HL167289-03 · fetched Nov 12, 2026
- Development of a highly sensitive and specific POCT testing asthma triggering allergic IgEFiscal year 2024 · $1.1MNIH RePORTER 2R44HL167289-02 · fetched Nov 12, 2026